Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Padres’ Maybin Suspended 25 Games by MLB After Flunked Drug Test

Don't Miss Out —
Follow us on:
Padres Center Fielder Cameron Maybin
Cameron Maybin of the San Diego Padres scores in the top of the fifth inning against the San Francisco Giants at AT&T Park in San Francisco, California, on June 24, 2014. Photographer: Thearon W. Henderson/Getty Images

July 23 (Bloomberg) -- San Diego Padres center fielder Cameron Maybin was suspended 25 games without pay after testing positive for an amphetamine, Major League Baseball said today in an e-mailed release.

The suspension of Maybin, 27, is effective immediately. He is hitting .247 with one home run and nine runs batted in 62 games this season.

Maybin released a statement through the Major League Baseball Players Association saying that his flunked drug test occurred while he was switching medication for a long-term condition and that “I was not trying in any way to gain an advantage in my baseball career.”

“I have been undergoing treatment for several years for a medical condition, Attention Deficit Disorder (ADD), for which I previously had a Therapeutic Use Exemption (TUE),” Maybin said in the statement. “Unfortunately, in my attempts to switch back to a medicine that had been previously OK’d, I neglected to follow all the rules and as a result I tested positive.”

To contact the editor responsible for this story: Rob Gloster at rgloster@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.